×
Terumo Receivables 2012-2024 | TRUMY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Terumo receivables for the quarter ending September 30, 2024 were
$1.194B
, a
7.83% increase
year-over-year.
Terumo receivables for 2024 were
$1.242B
, a
9.33% increase
from 2023.
Terumo receivables for 2023 were
$1.136B
, a
6.65% decline
from 2022.
Terumo receivables for 2022 were
$1.217B
, a
0.17% increase
from 2021.
View More
Terumo Receivables 2012-2024 | TRUMY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Terumo receivables for 2024 were
$1.242B
, a
9.33% increase
from 2023.
Terumo receivables for 2023 were
$1.136B
, a
6.65% decline
from 2022.
Terumo receivables for 2022 were
$1.217B
, a
0.17% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$194.8B
Boston Scientific (BSX)
$139.8B
Stryker (SYK)
$139.4B
EssilorLuxottica (ESLOY)
$110.1B
Medtronic (MDT)
$103.4B
Lonza Group Ag (LZAGY)
$43.7B
Haleon (HLN)
$41.2B
GE HealthCare Technologies (GEHC)
$38.7B
ResMed (RMD)
$34.3B
Koninklijke Philips (PHG)
$24.3B
Zimmer Biomet Holdings (ZBH)
$20.8B
Insulet (PODD)
$19.1B
Baxter (BAX)
$15B
Smith & Nephew SNATS (SNN)
$10.5B
Bio-Rad Laboratories (BIO)
$9.6B
BellRing Brands (BRBR)
$9.1B
Demant (WILYY)
$8.6B
Lantheus Holdings (LNTH)
$6.7B
Haemonetics (HAE)
$3.9B
ICU Medical (ICUI)
$3.8B
Prestige Consumer Healthcare (PBH)
$3.7B
Perrigo (PRGO)
$3.3B
Envista Holdings (NVST)
$3.2B
QuidelOrtho (QDEL)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
Neogen (NEOG)
$2.7B
GN Store Nord (GNNDY)
$2.6B
LeMaitre Vascular (LMAT)
$2.1B
Green Thumb Industries (GTBIF)
$1.6B
AtriCure (ATRC)
$1.5B